The Life Sciences Division

We serve the Life Sciences sector, through investment banking services including corporate finance, broking, research and M&A, additionally we have a particular focus on the convergence of tech related growth opportunities that form the basis of the ‘4th Industrial revolution,’ involving big data, genomics, epigenetics, proteomics, digital medicine, wearable and implantable devices. As well as Biotech companies becoming value drivers in the fields of nano-technologies, personalised medicines, biologics, vaccines, stem cell and gene therapies (regenerative medicine), and diagnostics. With similar macro drivers behind agri-tech, animal health and aquaculture innovation we seek to re-purpose/re-profile disruptive human health technologies to better manage extreme limited physical pressures on livestock, crops, agricultural land and water resources